130 related articles for article (PubMed ID: 21720608)
1. Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.
Jayaraman M; Karikumar K; Verma A; Modi KD
Am J Orthop (Belle Mead NJ); 2011 Mar; 40(3):E48-50. PubMed ID: 21720608
[TBL] [Abstract][Full Text] [Related]
2. Oral alendronate treatment for polyostotic fibrous dysplasia: a case report.
Kitagawa Y; Tamai K; Ito H
J Orthop Sci; 2004; 9(5):521-5. PubMed ID: 15449129
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates in polyostotic fibrous dysplasia.
Khadilkar VV; Khadilkar AV; Maskati GB
Indian Pediatr; 2003 Sep; 40(9):894-6. PubMed ID: 14530553
[TBL] [Abstract][Full Text] [Related]
4. Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia.
Rastogi A; Bhadada SK; Bhansali A
Indian J Pediatr; 2012 May; 79(5):667-9. PubMed ID: 21761121
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate therapy in polyostotic fibrous dysplasia.
Kumar S
Indian Pediatr; 2004 Oct; 41(10):1069-70. PubMed ID: 15523142
[No Abstract] [Full Text] [Related]
6. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
7. Fibrous dysplasia of the craniofacial bones.
Lai WS; Lee JC
J Am Osteopath Assoc; 2013 Aug; 113(8):641. PubMed ID: 23918916
[No Abstract] [Full Text] [Related]
8. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome.
Zacharin M; O'Sullivan M
J Pediatr; 2000 Sep; 137(3):403-9. PubMed ID: 10969268
[TBL] [Abstract][Full Text] [Related]
9. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.
Kochar IP; Kulkarni KP
Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120
[No Abstract] [Full Text] [Related]
10. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome.
Lala R; Matarazzo P; Bertelloni S; Buzi F; Rigon F; de Sanctis C
Acta Paediatr; 2000 Feb; 89(2):188-93. PubMed ID: 10709889
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
[TBL] [Abstract][Full Text] [Related]
12. [Fibrous dysplasia of bone in a 12-year old girl].
Bieniasz J; Maj A; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):69-72. PubMed ID: 16704865
[TBL] [Abstract][Full Text] [Related]
13. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood.
Chan B; Zacharin M
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):75-80. PubMed ID: 16509531
[TBL] [Abstract][Full Text] [Related]
14. Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction.
Wu D; Ma J; Bao S; Guan H
Rheumatol Int; 2015 Apr; 35(4):767-72. PubMed ID: 25230905
[TBL] [Abstract][Full Text] [Related]
15. Alendronate and pharmacological doses of 1alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia.
Yamamoto T; Ozono K; Shima M; Yoshikawa H; Okada S
J Bone Miner Metab; 2002; 20(3):170-3. PubMed ID: 11984700
[No Abstract] [Full Text] [Related]
16. Bisphosphonate therapy for fibrous dysplasia.
DiMeglio LA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
[TBL] [Abstract][Full Text] [Related]
17. Hypophosphatemic rickets and osteomalacia in polyostotic fibrous dysplasia.
Chattopadhyay A; Bhansali A; Mohanty SK; Khandelwal N; Mathur SK; Dash RJ
J Pediatr Endocrinol Metab; 2003; 16(6):893-6. PubMed ID: 12948303
[TBL] [Abstract][Full Text] [Related]
18. The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance.
Pepe J; Petrucci MT; Mascia ML; Piemonte S; Fassino V; Romagnoli E; Minisola S
Calcif Tissue Int; 2008 Jun; 82(6):418-26. PubMed ID: 18528609
[TBL] [Abstract][Full Text] [Related]
19. Response letter to the article: recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia: a novel molecular mechanism.
Namazi H
Indian J Pediatr; 2012 Nov; 79(11):1535; author reply 1535-6. PubMed ID: 22231769
[No Abstract] [Full Text] [Related]
20. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.
Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
